经非扩张性眼上静脉直接入路栓塞海绵窦区硬脑膜动静脉瘘的系统综述及示例病例
本系统综述纳入5篇报告共8次经眼上静脉直接穿刺尝试,评估在眼上静脉管径、通畅性或血管造影可见性不良时行海绵窦区硬脑膜动静脉瘘栓塞的技术可行性。8次尝试中6次完成穿刺、导航及栓塞并即刻闭塞,2次因静脉细小、狭窄或纤维化无法通过而失败。作者的示例病例术后3个月完全闭塞。
要点
- 非扩张、狭窄或血管造影不显影的眼上静脉在筛选病例中仍可能被外科识别并置管。
- 常规静脉入路失败或不可行时,可在经验丰富的中心将直接眼上静脉穿刺作为补救策略。
- 现有证据样本极小且选择性报告,不能用于估算预期成功率或安全性。
核心结论
- 已发表病例经验表明,即使眼上静脉非扩张、通畅性受损或血管造影可见性差,直接穿刺在技术上仍可能可行。
- 该入路在常规静脉路径不可行时可由经验丰富的中心作为补救选项考虑。
- 现有证据规模过小且存在选择性偏倚,不足以估计预期成功率、安全性或任一入路或栓塞技术的优劣。
研究设计与样本
- 本系统综述遵循PRISMA 2020规范,检索MEDLINE、CINAHL、PsycINFO、EMBASE、Cochrane图书馆和Scopus数据库。
- 检索时间为2026年4月,纳入描述眼上静脉直接暴露、穿刺、置管或尝试置管且具有足够病例级技术细节的报告。
- 管径、通畅性和血管造影可见性分别进行分类,结局以原始计数汇总。
- 共纳入5篇报告,包含8次已发表的穿刺尝试;机构示例病例不计入综述分母。
关键影像表现/征象
- 文献病例均未报告眼上静脉的具体管径数值。
- 通畅性方面:4次尝试描述为血栓形成,1次为闭塞,1次为狭窄或变窄,1次无梗阻报告,1次未报告。
- 血管造影可见性的描述不完整。
- 2次尝试因静脉细小、狭窄或纤维化无法通过而失败。
诊断标准与关键数值
- 8次已发表穿刺尝试中,6次报告了直接眼上静脉置管、靶区导航及栓塞的完整操作序列。
- 6例成功治疗的病例均实现即刻血管造影闭塞和临床改善。
- 5例有可提取数据的成功治疗病例中,配对视力均改善。
- 6例成功病例均未报告眼上静脉入路相关并发症,但不良事件报告和随访异质性较大,仅1例明确报告了随访血管造影。
临床应用与阅片要点
- 当常规经静脉入路失败或不可行时,可直接暴露眼上静脉进行穿刺置管作为补救性治疗策略。
- 术前应充分评估眼上静脉的解剖位置和可及性,即使血管造影不显影也不能完全排除穿刺可能。
- 操作中需注意细小、狭窄或纤维化的静脉可能导致导丝导管无法通过。
- 术后应安排临床随访和影像学随访以确认闭塞效果,现有文献中明确报告随访血管造影的比例很低。
局限性
- 全部文献病例均未报告眼上静脉管径数值,血管造影可见性描述不完整,影像学定义不一致。
- 证据仅来自5篇报告共8次尝试,样本量过小,且存在显著的发表偏倚和报告偏倚。
- 不良事件报告和随访方案异质性大,仅1例明确报告随访血管造影,无法可靠估计安全性。
- 缺乏与其他入路或栓塞技术的对照比较,无法评估相对优劣。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To identify and technically characterize published attempts at direct superior ophthalmic vein (SOV) access for cavernous sinus dural arteriovenous fistula (CCF; indirect carotid-cavernous fistula) when SOV caliber, patency, or angiographic visibility was unfavorable, and to describe a separate institutional illustrative case.
METHODS: We performed a PRISMA 2020-compliant systematic review with descriptive technical synthesis. MEDLINE, CINAHL, PsycINFO, EMBASE, the Cochrane Library, and Scopus were searched in April 2026. Eligible reports described direct exposure, puncture, cannulation, or attempted cannulation of the SOV itself and provided sufficient case-level technical detail. Caliber, patency, and angiographic visibility were classified separately. Outcomes were summarized as raw counts. The institutional case was not included in review denominators.
RESULTS: Five reports provided eight published access attempts. Numerical SOV diameter was not reported in any literature case. Patency was described as thrombosed in four attempts, occluded in one, stenosed or narrowed in one, without reported obstruction in one, and not reported in one. Angiographic visibility was incompletely characterized. The complete sequence of direct SOV cannulation, target-compartment navigation, and embolization was reported in six attempts. Two attempts failed because a small, stenotic, or fibrotic vein could not be traversed. All six successfully treated cases had immediate angiographic occlusion and clinical improvement. Paired visual acuity improved in the five successfully treated cases with extractable data. No SOV-access complication was reported in those six cases, but adverse-event reporting and follow-up were heterogeneous, and only one had explicitly reported follow-up angiography. The institutional case had complete occlusion at 3 months.
CONCLUSIONS: Published case-based experience documents that direct SOV access can be technically feasible despite non-dilation, impaired patency, or poor angiographic visibility. It may be considered a salvage option in experienced centers when conventional venous routes are not feasible. However, the evidence is too small and selected to estimate expected success, safety, or superiority of any access or embolization technique.
KEY POINTS: • Non-dilated, stenosed, or angiographically occult superior ophthalmic vein with or without thrombosis may remain surgically identifiable and catheterizable for treatment in selected carotid-cavernous fistulas. • Direct superior ophthalmic vein access may be considered a salvage strategy option in experienced centers after failed or infeasible conventional transvenous access. • The complete sequence of direct SOV cannulation, target-compartment navigation, and embolization was reported in six of eight published access attempts. These counts are not estimates of expected procedural success. • The evidence is limited to five reports with heterogeneous anatomy, incomplete imaging definitions, variable follow-up, and substantial publication and reporting bias.
引用
- Srinivasan, McCloskey, Jin, et al. Direct access of non-dilated superior ophthalmic vein for embolization of cavernous sinus dural arteriovenous fistula: a systematic review and illustrative case. Neuroradiology. 2026. PMID: 42635760. doi:10.1007/s00234-026-04151-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。